Saida Ortolano

Title: Saida Ortolano: Innovator in Lysosomal Storage Disease Treatment

Introduction

Saida Ortolano is a notable inventor based in Vigo, Spain. He has made significant contributions to the field of pharmacology, particularly in the treatment of lysosomal storage diseases. His innovative approach has the potential to improve the lives of many patients suffering from these conditions.

Latest Patents

Saida Ortolano holds a patent for the "Use of pharmacological chaperones for the treatment of lysosomal storage diseases." This invention focuses on the use of galactose analogues that stabilize the structure of the α-GalA enzyme. It is particularly aimed at treating Fabry disease, a specific type of lysosomal storage disorder. The patent also includes pharmacological compositions containing effective amounts of these galactose analogues for therapeutic use.

Career Highlights

Throughout his career, Ortolano has worked with prominent institutions such as Fundación Biomédica Galicia Sur and Universidad de Vigo. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Saida Ortolano has collaborated with notable colleagues, including Pedro Besada Pereira and Carmen Teran Moldes. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Saida Ortolano's work in pharmacological chaperones represents a significant advancement in the treatment of lysosomal storage diseases. His contributions are paving the way for new therapeutic options for patients in need.